News & Events
Signify Research’s latest external press coverage, company news and updates on key industry events that our analysts are attending
Intelerad acquires competitor Ambra Health to form $1.7B enterprise imaging giant
15th October 2021 – Featured on Fierce Healthcare – Intelerad Medical Systems is acquiring cloud-based medical imaging company Ambra Health in a major radiology software deal. The companies did not disclose financial details of the deal but estimate the newly formed entity to be worth $1.7 billion. It marks Intelerad’s fourth deal in 2021, following the heels […]
Hg’s Intelerad to Buy Ambra Health for $250 Million-Plus in Radiology Software Deal
October 14th 2021 – Featured on Bloomberg – Intelerad Medical Systems Inc. has agreed to acquire Ambra Health, a cloud-based medical imaging manager, in a deal that values the combined entity at $1.7 billion, according to a statement provided to Bloomberg. Intelerad, a medical imaging software company backed by European buyout firm Hg, will pay more than $250 million […]
6 Key Drivers of Restoring Teleradiology
15th September 2021 – Written by Arun Gill – Featured on ITN Online (Imaging Technology News) – Teleradiology read volumes dropped 22% in 2020, but rapid bounce back is already well underway. The closely tied relationship between teleradiology reading services and diagnostic imaging procedures resulted in an enormously challenging year for the teleradiology market. As […]
Nihon Kohden’s Acquisition of AMP3D Further Highlights Interest of Analytics in the Clinical World
24th August 2021 – Written by Kelly Patrick – Featured on Healthcare Business Euro News – On the 27th of July 2021, the US subsidiary of Nihon Kohden (Nihon Kohden Digital Health Solutions Inc.) announced that it was to acquire 100% of the shares of U.S.-based Advanced Medical Predictive Devices, Diagnostics and Displays Inc. (“AMP3D”). AMP3D focuses […]
Funding for AI Drug Development Skyrockets in 2021
16th August 2021 – Written by Imogen Fitt – Featured on the Science Advisory Board – The market for artificial intelligence (AI) in drug development and clinical trials has seen renewed interest in recent months, with total funding in the industry now reaching $10.7 billion, according to a report published by U.K. market insights firm […]